| Outcome . | Subcutaneous group n(%) . | Intravenous group n(%) . | Difference (95% CI) . | p-value for difference . | |
|---|---|---|---|---|---|
| Time spend on insertiona | < 5 min: 5–20 min: > 20 minb: | 18 (85%) 2 (10%) 1 (5%) | 7 (32%) 9 (41%) 6 (27%) | N/A | 0.001 |
| Death during hospitalization | 0 (0%) | 0 (0%) | N/A | N/A | |
| Delirium | 0 (0%) | 3 (14%) | 0.23 | ||
| n, mean (SD) | n, mean (SD) | ||||
| .......................... | |||||
| Pain of insertion (0–100 VAS) | n = 21, 7.3 (10.4) | n = 20, 13.0 (13.4) | 5.7 (−1.9; 13.2) | 0.13 | |
| Discomfort during infusion (0–100 VAS) | n = 18, 4.5 (11.8) | n = 18, 4.7 (7.5) | 0.2 (−6.9; 4.5) | 0.74 | |
| Outcome . | Subcutaneous group n(%) . | Intravenous group n(%) . | Difference (95% CI) . | p-value for difference . | |
|---|---|---|---|---|---|
| Time spend on insertiona | < 5 min: 5–20 min: > 20 minb: | 18 (85%) 2 (10%) 1 (5%) | 7 (32%) 9 (41%) 6 (27%) | N/A | 0.001 |
| Death during hospitalization | 0 (0%) | 0 (0%) | N/A | N/A | |
| Delirium | 0 (0%) | 3 (14%) | 0.23 | ||
| n, mean (SD) | n, mean (SD) | ||||
| .......................... | |||||
| Pain of insertion (0–100 VAS) | n = 21, 7.3 (10.4) | n = 20, 13.0 (13.4) | 5.7 (−1.9; 13.2) | 0.13 | |
| Discomfort during infusion (0–100 VAS) | n = 18, 4.5 (11.8) | n = 18, 4.7 (7.5) | 0.2 (−6.9; 4.5) | 0.74 | |
Abbreviations: VAS: Visual analogue scale, N/A: Not applicable
aOriginal groups are collapsed due to the low number of events in some groups.
bRequiring assistance from another staff member
| Outcome . | Subcutaneous group n(%) . | Intravenous group n(%) . | Difference (95% CI) . | p-value for difference . | |
|---|---|---|---|---|---|
| Time spend on insertiona | < 5 min: 5–20 min: > 20 minb: | 18 (85%) 2 (10%) 1 (5%) | 7 (32%) 9 (41%) 6 (27%) | N/A | 0.001 |
| Death during hospitalization | 0 (0%) | 0 (0%) | N/A | N/A | |
| Delirium | 0 (0%) | 3 (14%) | 0.23 | ||
| n, mean (SD) | n, mean (SD) | ||||
| .......................... | |||||
| Pain of insertion (0–100 VAS) | n = 21, 7.3 (10.4) | n = 20, 13.0 (13.4) | 5.7 (−1.9; 13.2) | 0.13 | |
| Discomfort during infusion (0–100 VAS) | n = 18, 4.5 (11.8) | n = 18, 4.7 (7.5) | 0.2 (−6.9; 4.5) | 0.74 | |
| Outcome . | Subcutaneous group n(%) . | Intravenous group n(%) . | Difference (95% CI) . | p-value for difference . | |
|---|---|---|---|---|---|
| Time spend on insertiona | < 5 min: 5–20 min: > 20 minb: | 18 (85%) 2 (10%) 1 (5%) | 7 (32%) 9 (41%) 6 (27%) | N/A | 0.001 |
| Death during hospitalization | 0 (0%) | 0 (0%) | N/A | N/A | |
| Delirium | 0 (0%) | 3 (14%) | 0.23 | ||
| n, mean (SD) | n, mean (SD) | ||||
| .......................... | |||||
| Pain of insertion (0–100 VAS) | n = 21, 7.3 (10.4) | n = 20, 13.0 (13.4) | 5.7 (−1.9; 13.2) | 0.13 | |
| Discomfort during infusion (0–100 VAS) | n = 18, 4.5 (11.8) | n = 18, 4.7 (7.5) | 0.2 (−6.9; 4.5) | 0.74 | |
Abbreviations: VAS: Visual analogue scale, N/A: Not applicable
aOriginal groups are collapsed due to the low number of events in some groups.
bRequiring assistance from another staff member
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
